Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Boehringer, Amgen and Novartis rank top for cardiovascular patient groups
Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups.
Read more
GSK and Microsoft tackle Nepal disease transmission
A new disease surveillance project to curb the spread of known and unknown pathogens, especially mosquito-borne illnesses, has been launched by GSK and Microsoft in Nepal.
First malaria vaccine granted WHO prequalification
The World Health Organization (WHO) has granted the first prequalification for a malaria vaccine to GSK’s Mosquirix in an important step toward immunising children against the disease.
Access win for HIV patients in sub-Saharan Africa
The injectable HIV treatment cabotegravir is set to become more widely available in sub-Saharan Africa following a new licensing agreement.
Sanofi lights ‘Beacon of Hope’ in race for greater diversity
Sanofi has joined the ‘Beacon of Hope’ programme – a Novartis initiative seeking to address racial inequality in clinical trials, health and education and to create greater diversity across R&D structures.
ABPI wins prestigious PIF TICK status
The Association of the British Pharmaceutical Industry (ABPI) has been awarded PIF TICK trusted healthcare information creator status by the Patient Information Forum, in recognition of its commitment to providing clear, accurate information for patients and the public
Vaccines and sustainability focus for GSK
In its annual Palio meeting, GSK discusses the growing threat to human health from infectious disease with a group of experts in immunology, vaccinology and epidemiology.
Global health agencies collaborate to ease Ebola outbreak
CEPI, Gavi and WHO have announced a collective effort to support the Ugandan Government’s response to the recent Ebolavirus outbreak.
New AZ study reveals extent of CKD worldwide
Chronic kidney disease is present in one in 10 adults, according to a recent study by AstraZeneca. Read the article for more details.
Loading posts...
« Previous
1
…
11
12
13
14
15
16
Next »